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Abstract
Purpose Hypoxia in tumors is generally associated with
chemoresistance and radioresistance. However, the correla-
tion between the heterodimeric hypoxia-inducible factor-1
(HIF-1) and the multidrug resistance (MDR1) gene/trans-
porter P-glycoprotein (P-gp) has not been clearly investi-
gated. This study aims at examining the expression levels
of HIF-1 and MDR1/P-gp in human colon carcinoma tis-
sues and cell lines (HCT-116, HT-29, LoVo, and SW480)
and ascertaining whether HIF-1 plays an important role in
tumor multidrug resistance with MDR1/P-gp.
Methods The expression and distribution of HIF-1 and
P-gp proteins were detected in human colon carcinoma tis-
sues and cell lines by immunohistochemistry and immuno-
cytochemistry using streptavidin/peroxidase (SP) and
double-label immunoXuorescence methods. HIF-1 and
MDR1 mRNA expression levels in cell lines were analyzed
using RT-PCR under normoxic and hypoxic conditions,
respectively.
Results The immunohistochemical method shows that
HIF-1 and P-gp expression were not correlated with gen-
der, age, location, and diVerentiation degree (P > 0.05).
However, the expression of HIF-1 and P-gp at diVerent
Dukes’ stages and whether involved in lymphatic invasion
shows a signiWcant diVerence (P < 0.05). Correlation
analysis displays that HIF-1 protein expression was corre-
lated signiWcantly with P-gp expression (P < 0.01). Double-
label immunoXuorescence demonstrates that coexpression
of HIF-1 and P-gp does exist in human colon carcinoma
tissues. The mRNA expression of HIF-1 and MDR1 was
detected in the four human colon carcinoma cell lines under
both normoxia and hypoxia. Optical density values repre-
senting mRNA expression levels of HIF-1 and MDR1
were found to be signiWcantly higher in the same type cells
under hypoxic conditions than that under normoxic condi-
tions, respectively (P < 0.01). However, no signiWcant
diVerences of HIF-1 or MDR1 mRNA expression were
found among these cell lines, which exposed under the
same PaO2 cultural conditions (P > 0.05). And the immu-
nocytochemistry results were corresponding with the analy-
sis of mRNA expression.
Conclusions These results suggest that hypoxia induce
the expression of HIF-1 and MDR1/P-gp in colon carci-
noma and HIF-1 expression may be associated with the
gene MDR1 (P-gp) and interactively involved in the occur-
rence of tumor multidrug resistance.
Keywords Hypoxia · Hypoxic-inducible factor-1 · 
Multidrug resistance · P-glycoprotein · Human colon 
carcinoma
Introduction
DeWciencies in oxygenation are widespread in solid
tumors. Hypoxic cell areas have been identiWed in several
studies, either by immunostaining of hypoxic cells in sec-
tions of rodent and human tumors or by oxygen pressure
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(Durand and Raleigh 1998; Partridge et al. 2001). And HIF-1
plays a central role in the tumor bionomics changes caused
by hypoxia.
HIF-1 is a bHLH-PAS transcription factor that plays an
essential role in oxygen homeostasis, which is a heterodi-
mer composed of HIF-1 and HIF-1b subunits. Both
transcription factors contain basic helix-loop-helix (bHLH)
and per-ARNT-sim (PAS) domains that are required for
dimerization and DNA binding, and these domains control
various critical embryogenic and pathogenic events (Iyer
et al. 1998; Semenza 2000). HIF-1 has been previously
identiWed as an aryl hydrocarbon nuclear translocator
(ARNT), whereas HIF-1 is the unique, O2-regulated sub-
unit that determines HIF-1 activity (Semenza 1999). Under
non-hypoxic conditions, HIF-1 is subject to rapid ubiquiti-
nation and proteasome degradation. This degradation is
aVected by the von Hippel-Lindau (VHL) protein (Maxwell
et al. 1999). HIF-1 has been recognized as an important
regulatory protein in the transcription of a large number of
genes related to glucose transport, glycolysis, erythropoie-
sis, cell proliferation/survival, and angiogenesis (Semenza
2002). In human tumors, overexpression of HIF-1 may
activate metabolic and pathogenic pathways that are related
to tumor angiogenesis, growth, invasion and metastasis
(Fang et al. 2007; Jiang and Feng 2006; Koukourakis et al.
2002; Semenza 1999).
Thomlinson and Gray (Thomlinson and Gray 1955)
Wrstly proposed that within the tissue of solid tumors viable
hypoxic conditions exist and hence chemotherapy-resistant
and radiotherapy-resistant cells occur at a constant distance
(100.150 m) between blood vessels and necrotic tissue in
areas of reduced oxygen supply. There is also general con-
sent that hypoxia in the depth of solid tumors dramatically
decreases the chemosensitivity of tumor cells and that
experimental hypoxia promotes drug resistance to antican-
cer agents in a variety of cell lines (Teicher 1994). How-
ever, no correlation between hypoxia and either increased
expression or ampliWcation of genes conferring multidrug
resistance (MDR), e.g., the genes for the MDR transporters
P-glycoprotein (P-gp), MDR-associated protein, or lung
resistance-associated protein, has yet been presented. These
genes, which constitute the major constraint to increased
eYcacy of chemotherapeutic anticancer agents, may be reg-
ulated by HIF-1, which are stabilized under hypoxia but
undergo enhanced degradation under normoxia (Hofer
et al. 2002; Semenza 2001). Therefore, the purpose of this
study was to investigate the expression levels and relation-
ship between HIF-1 and MDR1/P-gp in human colon car-
cinoma tissues and cell lines and exploring whether HIF-1




The human colon carcinoma cell lines (HCT-116, HT-29,
LoVo, SW480) were stored in our laboratory and were cul-
tured in high-glucose Dulbecco’s modiWed Eagle’s medium
(DMEM; Gibco Corporation, USA), supplemented with
10% fetal bovine serum (Hyclone, USA) and antibiotics
(1% penicillin and 1% streptomycin). For hypoxia expo-
sure, four types of cells were cultured for 24 h in a modula-
tor incubator chamber at 37°C with 1% O2, 5% CO2, and
94% N2.
Patients and tumor specimens
Fifty-eight tissue specimens of colon carcinomas obtained
from the Department of Pathology, Southwest Hospital,
Third Military Medical University, Chongqing, China,
were used in this immunohistochemistry (IHC) study
(Table 1). The patients ranged in age from 21 to 85 (mean,
54 years), including 30 men and 28 women. The whole
specimens were classiWed according to level of diVerentia-
tion: 8 cases were well diVerentiated, 35 were moderately
well diVerentiated, and 15 were poorly diVerentiated. The
tumors were classiWed into 4 stages according to the Dukes’
system as follows: Dukes A (11), Dukes B (27), Dukes C
(15), and Dukes D (5). None of the patients had a known
history of familial polyposis syndrome or hereditary nonpo-
lyposis colorectal cancer syndrome. All above resected tis-
sue specimens were Wxed in 10% formalin, embedded in
paraYn, and cut into 4-m serial sections. Moreover, eight
fresh surgical specimens of colon carcinomas (men 4,
women 4; patients mean age 56, ranging from 35 to 78)
were used in the study of double-label immunoXuores-
cence. The level of diVerentiation was that 2 cases were
well diVerentiated, 3 were moderately well diVerentiated,
and 3 were poorly diVerentiated. The Dukes’ stages were
that Dukes A and B (3), Dukes C and D (5). All specimens
were resected surgically between 2004 and 2006, and the
diagnoses were conWrmed pathologically. No patients had
undergone preoperative radiotherapy or chemotherapy. The
clinical features of all patients, including stage, histological
type, liver metastasis, and lymph node metastasis were
obtained from clinical and pathological reports.
Experimental groups
Approximately 106 cells were plated on culture dishes
(60 mm). The experimental samples were divided into two
groups: (1) normoxia group, cultured under normoxic con-
ditions (20% O2, 5% CO2, and 75% N2) and (2) hypoxia123
J Cancer Res Clin Oncol (2010) 136:1697–1707 1699group, cultured under hypoxic conditions (1% O2, 5% CO2,
and 94% N2).
Immunohistochemistry
IHC was performed on 4-m-thick sections of formalin-
Wxed (10%), paraYn-embedded tissues. A commercial
streptavidin/peroxidase (SP) kit (Beijing ZhongShan
Golden Bridge Biotech CO., LTD, China) was used for
IHC. Sections were deparaYnaged in xylene, taken
through ethanol and microwaved with target retrieval
solution (citrate sodium buVer) for 20 min. Then sections
were incubated with 3% hydrogen peroxide to block
endogenous peroxidase activity. Subsequent steps were
performed according to the manufacturer’s instructions.
The sections were respectively incubated with anti-HIF-
1 and anti-P-gp-speciWc rabbit polyclonal antibodies
(both at a working dilution of 1:100; Wuhan Boster Bio-
logical Project CO., LTD, China). The primary antibody
reaction was carried out at 4°C overnight. For a negative
control, sections were incubated with phosphate-buVered
saline (PBS; 0.01 mol/l, pH7.4) instead of the primary
antibodies. 3,3-diaminobenzidine (DAB)/hydrogen
peroxide (Beijing ZhongShan Golden Bridge Biotech
CO., LTD, China) was used to detect antigen–antibody
binding, and slides were counterstained with hematoxylin.
Clear brown-yellow staining was restricted to the cyto-
plasm, nuclei or cell membrane that indicated a positive
result of HIF-1 or P-gp expression.
Double-label immunoXuorescence
Double-label immunoXuorescence staining was performed
on 7–10-m-thick sections of paraformaldehyde-Wxed
(4%), OTC-embedded, frozen-sliced tissues. Sections were
thoroughly washed in PBS and incubated with 1% BSA for
30 min. Then, sections were incubated with Wrst primary
antibody MDR1 (1:100) for 8 h at 4°C and Cy3-labeled
goat anti-rabbit IgG (1:100; Wuhan Boster Biological Pro-
ject CO., LTD, China) for 1 h at 25°C by turns. After being
washed in PBS and blocked with 1% BSA for 30 min, the
secondary primary antibody HIF-1 (1:100) and FITC-
labeled goat anti-rabbit IgG (1:100) (Wuhan Boster Biolog-
ical Project CO., LTD, China) were added to the sections in
order for 8 h at 4°C and 1 h at 25°C, respectively. The pro-
tein expression was observed by Xuorescence microscope
after being counterstained with 4,6-diamidino-2-phenylin-
dole 2HCI (DAPI) and mounted with water-solubility
mounting agents. For a negative control, sections were
incubated with PBS instead of the primary antibodies.
Table 1 Clinicopathological features and expression of HIF-1 and P-gp in human colon carcinoma tissue
* 2 P value
Clinicopathological Wndings Total 
(ParaYn-embedded 
tissues)
HIF-1 (+)/ HIF-1 (+)/ HIF-1 (¡)/ HIF-1 (¡)/
P-gp (+) P-gp (¡) P-gp (+) P-gp (¡)
(n, %)
All 58 24 (41.4) 10 (17.2) 3 (5.2) 21 (36.2)
Gender P = 0.513*
Male 30 12 (40.0) 7 (23.3) 2 (6.7) 9 (30.0)
Female 28 12 (42.9) 3 (10.7) 1 (3.5) 12 (42.9)
Age P = 0.753*
<60 25 9 (36.0) 4 (16.0) 1 (4.0) 11 (44.0)
¸60 33 15 (45.5) 6 (22.0) 2 (6.1) 10 (30.4)
Location P = 0.398*
Left hemicolon 30 15 (50.0) 5 (16.7) 2 (6.7) 8 (26.6)
Right hemicolon 28 9 (32.1) 5 (17.9) 1 (3.6) 13 (46.4)
DiVerentation degree P = 0.103*
Well & Moderately diVerentiated 43 17 (39.5) 5 (11.6) 2 (4.7) 19 (44.2)
Poorly diVerentiated 15 7 (46.7) 5 (33.3) 1 (6.7) 2 (13.3)
Dukes’ stage P = 0.003*
A & B 38 12 (31.6) 4 (10.5) 2 (5.3) 20 (52.6)
C & D 20 12 (55.0) 6 (30.0) 1 (10.0) 1 (5.0)
Lymphatic invasion P = 0.005*
Positive 19 11 (57.9) 6 (31.5) 1 (5.3) 1 (5.3)
Negative 39 13 (33.3) 4 (10.3) 2 (5.1) 20 (51.3)123
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After cell cultures under normoxia or hypoxia, the cover
slips that covered the monolayer cells were washed with
PBS and Wxed for 30 min at room temperature with 4%
paraformaldehyde. SP immunocytochemical techniques
were used to detect the expression of HIF-1 and P-gp. The
working dilution of both antibodies was 1:100. Subsequent
steps were performed according to the manufacturer’s
instructions. For a negative control, PBS was used as the
primary antibody instead of HIF-1 protein, and P-gp
expression was analyzed by a cellular image analysis sys-
tem (Image-Pro Plus 4.5, Media Cybernetics, Inc., USA).
Expression levels of protein were quantiWed using the mean
optical density value of the positive signals.
Reverse transcriptase-polymerase chain reaction analysis 
(RT-PCR)
Total RNA was extracted respectively from HCT-116,
HT-29, LoVo, and SW480 cells with TRIZOL (Shanghai
Sangon Biological Engineering Technology & Services
Co., Ltd, China). Two oligomers of primers were synthe-
sized on the basis of the designed sequences (Primer
Premier 5.0). HIF-1 mRNA was ampliWed by using
5-CTTCTGGATGCTGGTGATT-3 as the forward primer
and 5-TCCTCGGCTAGTTAGGGTA-3 as the reverse
primer. MDR1 mRNA was ampliWed by using 5-GGAGG
AGCAAAGAAGAAG-3 as the forward primer and
5-AATGTAAGCAGCAACCAG-3 as the reverse primer.
The primers of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were synthesized according to previous studies
(F, 5-CAAATTCCATGGCACCGTCA-3 and R, 5-GGA
GTGGGTGTCGCTGTTGA-3). GAPDH was used as an
internal control. The primer pair ampliWed a 324-base pair
(bp) fragment as HIF-1, a 369-bp fragment as MDR1, and
a 715-bp fragment as GAPDH. All the primers were syn-
thesized by Shanghai Sangon Biological Engineering Tech-
nology & Services Co., Ltd. RT-PCR was performed with
the isolated RNA and the oligomers as templates and prim-
ers, respectively by using Takara RT-PCR V3.0 Kit. For
HIF-1 and MDR1, the cDNA was ampliWed with 35
cycles of denaturation for 2 min at 94°C, annealing for 30 s
at 61.5°C, and extension for 30 s at 72°C. For GAPDH, the
cDNA was ampliWed with 35 cycles of denaturation for
5 min at 94°C, annealing for 45 s at 57°C, and extension for
45 s at 72°C. After ampliWcation, products were loaded
onto a 1.5% agarose gel in 1 £ Tris Cl-acetate-ethylene
diamine tetraacetic acid (EDTA; TAE) buVer and the spe-
ciWc bands were visualized with ethidium bromide (EB)
and photographed under ultraviolet light. RT-PCR without
reverse transcriptase yielded no speciWc bands. HIF-1,
MDR1, and GAPDH mRNA levels were quantiWed with
the aid of computer software (Quantity One 4.4.0, BIO-
RAD, USA). For semi-quantitative analysis, HIF-1 and
MDR1 PCR products were normalized to GAPDH by the
mean optical density value of the speciWc bands.
Statistical analysis
All results were expressed as mean § standard deviation
(SD). Statistical analysis, including the Chi-square test, cor-
related Spearman test, one-way ANOVA test, and t test,
were carried out using the software package SPSS 13.0.
The signiWcance level was set at 5% for each analysis.
Results
Expression of HIF-1 and P-gp in human colon carcinoma 
tissue
HIF-1 protein expression was predominantly localized in
the cytoplasm of tumor cells (Fig. 1a), part of in nuclei
Fig. 1 IHC staining for HIF-1 in human colon carcinoma tissue.
a Strong HIF-1 immunoreactivity in cytoplasm of tumor cells
(£400). b HIF-1 immunoreactivity in nuclei of tumor cells (£200)123
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inWltrating regions. P-gp expression was mainly localized
in cytoplasm and cytomembrane of tumor cells (Fig. 2a,
b). According to the 58 tissue specimens, the statistical
analysis of HIF-1 and P-gp expression was as follows
(Table 1). Of the 58 paraYn-embedded cases, 24 (41.4%)
cases were positive expression with HIF-1 (+)/P-gp (+),
10 (17.2%) cases were HIF-1 (+)/P-gp (¡), 3 (5.2%)
cases were HIF-1 (¡)/P-gp (+), and 21 (36.2%) cases
were HIF-1 (¡)/P-gp (¡). Among these four groups,
signiWcant diVerences were observed for Dukes’ stage
[HIF-1 (+)/P-gp (+), HIF-1 (+)/P-gp (¡), and HIF-1
(¡)/P-gp (+) cases more likely to have a higher grade
stage, P = 0.003] and lymphatic invasion [HIF-1 (+)/
P-gp (+) and HIF-1 (¡)/P-gp (+) cases more likely to
exist lymphatic invasion, P = 0.005]. Overall, no diVer-
ences of HIF-1 and P-gp expression were noted in the
gender, age, location, and diVerentation degree among
these four groups (P > 0.05).
Correlation between HIF-1 and P-gp expressions
The Spearman analysis showed that the expression level of
HIF-1 was signiWcantly associated with P-gp expression
(r = 0.574, P < 0.01; Table 2).
Coexpression of HIF-1 and P-gp in human colon carci-
noma tissue by double-label immunoXuorescence staining
In the eight fresh resected specimens, HIF-1 expression
was chieXy localized in cytoplasm of tumor cells, also part
in nuclei by using double-label immunoXuorescence stain-
ing method (Fig. 3a, d, green Xuorescence). Likewise, P-gp
expression was chieXy observed in cytoplasma and mem-
brane of tumor cells (Fig. 3b, e, red Xuorescence), and
coexpression phenomenon was also found in colon carci-
noma tissue (Fig. 3c, f, yellow).
Expression of HIF-1 and P-gp in colon carcinoma cells
after normoxic and hypoxic incubation
In the four experimental cell lines (HCT-116, HT-29,
LoVo, and SW480), the expression of HIF-1 and P-gp
were both observed, strongly expressed in the hypoxic
group, but weakly or negatively expressed in the normoxic
group. HIF-1 immunoreactivity was predominantly
located in cytoplasm, most of them were found around the
nuclei and part in nuclei (Fig. 4a–h). The expression of
P-gp was mainly found in cell cytoplasm and a bit in cyto-
membrane (Fig. 4i–p). Expression of HIF-1 protein and
P-gp was markedly enhanced after culture under hypoxic
conditions for 24 h. According to the expression diVerences
between the same cell line, image analysis revealed that
mean optical density representing HIF-1 or P-gp expres-
sion in the hypoxia group was signiWcantly higher than that
in the normoxia group (P < 0.01) (Table 3). However, no
signiWcant diVerences of HIF-1 or P-gp expression were
found among each cell line under the same cultural condi-
tions (P > 0.05).
HIF-1 and MDR1 mRNA expression in colon carci-
noma cells under normoxic and hypoxic conditions
RT-PCR revealed that HIF-1 and MDR1 mRNA was
strongly expressed in the hypoxia group of the four types of
cells, but all weakly expressed in the normoxia group
(Fig. 5). As far as the same target gene and cell were
Fig. 2 IHC staining for P-gp in human colon carcinoma tissue. Strong
P-gp immunoreactivity in cytoplasm and cytomembrane of tumor
cells. a, (£200); b, (£400)
Table 2 Association analysis between HIF-1 and P-gp expression in
human colon carcinoma tissue
R = 0.574, P < 0.01
P-gp 
(No. of cases)
HIF-1 (No. of cases) Total
Positive Negative
Positive 24 3 27
Negative 10 21 31
Total 34 24 58123
1702 J Cancer Res Clin Oncol (2010) 136:1697–1707concerned, optical density representing HIF-1 or MDR1
mRNA expression levels was signiWcantly higher in the
hypoxia group than that in the normoxia group (P < 0.01;
Table 4; Fig. 6). Likewise, no signiWcant diVerences of
HIF-1 or MDR1 mRNA expression were found among
each cell line under the same PaO2 cultural conditions
(P > 0.05). Obviously, RT-PCR analysis was totally consis-
tent with the results of the immunocytochemistry assays.
Fig. 3 Double-label immuno-
Xuorescence staining for HIF-1 
and P-gp in human colon carci-
noma tissues. a–c, (£200), d–f, 
(£400). (green shows HIF-1, 
red shows P-gp, yellow shows 
coexpression)
Fig. 4 Immunocytochemical staining for HIF-1 and P-gp in human
colon carcinoma cells under normoxia and hypoxia conditions. Very
weak HIF-1 and P-gp expression were detected in the four cells in
normoxia, (a–c) and (i–l). Strong HIF-1 and P-gp immunoreactivity
in cytoplasm of tumor cells was observed after hypoxia culture for
24 h, (e)–(h) and (m)–(p). a–h shows HIF-1, i–p shows P-gp.
HCT-116: Wrst vertical line; HT-29: second vertical line; LoVo: third
vertical line; SW480: last vertical line. d, i, j, k, o: (£200); else: (£400)123
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Chemotherapy is one of alternatives for treating cancers,
but a main obstacle in the development of eVective cancer
chemotherapy is MDR phenotype, which is one of the cru-
cial reasons leading to the failure of treatment. Overexpres-
sion of P-gp and multidrug resistance-associated protein
(MRP) are generally believed to be the mechanism respon-
sible for MDR of tumor cells. Hypoxia is a common feature
of many malignant tumors. The physiology and biochemis-
try of tumor cells changes to adapt hypoxia. HIF-1 is a key
factor in altering the biological characteristics of tumors
(Mabjeesh and Amir 2007; Jensen et al. 2006; Nagle and
Zhou 2006). Many studies indicated that hypoxia helped to
improve chemotherapy and radiotherapy resistance of
tumor (Magnon et al. 2007; O’Donnell et al. 2006; Schnitzer
et al. 2006; Sullivan et al. 2008). Better understanding the
inXuence of tumor MDR by hypoxia will help improve the
eVect of chemotherapy. It has been reported that HIF-1
protein was overexpressed in multiple types of human can-
cer, including lung, breast, prostate, gastric, and colon car-
cinomas, even in preneoplastic and premalignant lesions,
such as colonic adenoma, breast ductal carcinoma in situ,
and prostate intraepithelial neoplasia (Giatromanolaki et al.
2001; Liu et al. 2008; Schindl et al. 2002; Welsh et al.
2002). More importantly, Birner et al. (Birner et al. 2000)
found that the overexpression of HIF-1 is an important
marker in precancerous lesion such as early-stage cervical
cancer, cervical intra-epithelial neoplasia III, and early-
stage lymph node-negative breast cancer.
Hypoxia is well known to induce resistance to drugs and
radiation in solid tumors (Piret et al. 2006; Wu et al. 2007)
Table 3 Expression levels of HIF-1 and P-gp under normoxic and hypoxic conditions in human colon carcinoma cells
Note N, Normoxia; H Hypoxia
*
 P < 0.01, analysis of HIF-1 expression of the same type of cell under normoxic and hypoxic culture conditions, compared with normoxia group;
** P < 0.01, analysis of P-gp expression of the same type of cell under normoxic and hypoxic culture conditions, compared with normoxia group
Experimental group HCT-116 HT-29 LoVo SW480
HIF-1 N 0.1501 § 0.0062 0.1482 § 0.0041 0.1527 § 0.0045 0.1573 § 0.0037
H 0.3320 § 0.0071* 0.3309 § 0.0053* 0.3394 § 0.0109* 0.3376 § 0.0084*
P-gp N 0.1218 § 0.0043 0.1197 § 0.0038 0.1203 § 0.0033 0.1253 § 0.0052
H 0.2854 § 0.0078** 0.2757 § 0.0068** 0.2892 § 0.0041** 0.2884 § 0.0036**
Fig. 5 Expression of HIF-1 and MDR1 mRNA levels in cells under diVerent conditions as determined by RT-PCR. lane1: marker, lane2:
HCT-116, lane3: HT-29, lane4: LoVo, lane5: SW480 GAPDH is included as an internal control. (N normoxia; H hypoxia treatment for 24 h)
Table 4 Expression levels of HIF-1 and MDR1 mRNA under normoxic and hypoxic conditions in human colon carcinoma cells
Note N Normoxia; H Hypoxia
*  P < 0.01, analysis of HIF-1 mRNA expression of the same type of cell under normoxic and hypoxic culture conditions, compared with normoxia
group; ** P < 0.01, analysis of MDR1 mRNA expression of the same type of cell under normoxic and hypoxic culture conditions, compared with
normoxia group
Experimental group HCT-116 HT-29 LoVo SW480
AHIF-1/AGAPDH N 0.4901 § 0.0472 0.4872 § 0.0592 0.4824 § 0.0325 0.4941 § 0.0687
H 0.9989 § 0.0312* 0.9968 § 0.0618* 0.9978 § 0.0721* 0.9944 § 0.0576*
AMDR1/AGAPDH N 0.3932 § 0.0295 0.3952 § 0.0793 0.3937 § 0.0671 0.3961 § 0.0990
H 0.9909 § 0.0562** 0.9954 § 0.0388** 0.9972 § 0.0422** 0.9934 § 0.0764**123
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et al. 2001a, b). The reason that hypoxia contributes to drug
resistance in anticancer therapy has not yet been estab-
lished. It has been demonstrated that hypoxia reduces the
expression of DNA topoisomerase II, which renders cells
resistant to topoisomerase II-targeted drugs such as etopo-
side and doxorubicin (Ogiso et al. 2000). Furthermore, glu-
tathione S-transferase pi (GST-pi), which has been
demonstrated to be involved in the MDR phenotype, has
recently been shown to be up-regulated by hypoxia in
several cancer cell lines. A correlation between P-gp and
GST-pi has been reported (Weissenberger et al. 2000); this
report indicated that there may be a common mechanism
for regulating the expression of drug resistance–related pro-
teins. Graeber TG et al. (Graeber et al. 1996) have revealed
that a number of factors associated either directly or indi-
rectly with tumor hypoxia contributed to resistance to anti-
cancer drugs in a solid tumor in vivo. Cells in hypoxic
regions of a tumor stop or slow their rate of progression
through the cell cycle. This eVect is the result of increased
expression of speciWc proteins, e.g., the tumor suppressor
p53 and the cyclin-dependent kinase inhibitor p27Kip1
(Gardner et al. 2001; Wenger et al. 1998), which are
induced under hypoxic conditions. Because most anticancer
drugs are more eVective against rapidly proliferating cells
than nonproliferating cells, this slowing of cell proliferation
will lead to increased chemoresistance. Another way by
which hypoxia may contribute to drug resistance is through
reduced generation of endogenous nitric oxide (NO) under
hypoxic conditions, as recently evidenced in Matthews and
Yu et al. (Matthews et al. 2001; Yu et al. 2006). These
authors demonstrated that pharmacological inhibition of
NO generation abolished the drug resistance observed after
hypoxic incubation of tumor cells.
In addition, reactive oxygen species (ROS; e.g., H2O2)
have previously been shown to increase degradation of
HIF-1 via the ubiquitin–proteasome pathway. Endogenous
generation of ROS is a common feature of tumor cells and
may regulate neoplastic cell growth. Recent study demon-
strated that expression of P-gp is down-regulated on eleva-
tion of the intracellular redox state (Wartenberg et al. 2000,
2001a, b). Wartenberg et al. (Wartenberg et al. 2003) found
that a pronounced up-regulation of HIF-1 as well as P-gp
was achieved by cultivation of small tumor spheroids under
low oxygen pressure (physiological hypoxia) as well as
after treatment with CoCl2, which are known to induce
chemical hypoxia.
In this study, we observed and analyzed the expression
and relationship of HIF-1 and P-gp in 58 specimens by
using IHC. The expression of HIF-1 protein and P-gp
were signiWcantly higher in tissue samples classiWed as
Dukes’ stages C or D, involving lymph node metastasis,
than in samples classiWed as Dukes’ stages A or B, indicating
that HIF-1 was involved in tumor invasion and metastasis.
Thus, we believe that HIF-1 represents a biomarker for
premalignant lesions and tumor progression that warrants
clinical surveillance. Association analysis displays that
HIF-1 protein expression was signiWcantly correlated
with P-gp expression (P < 0.01). Moreover, double-label
immunoXuorescence demonstrates that coexpression of
HIF-1 and P-gp dose exist in human colon carcinoma tis-
sue. IHC studies of HIF-1 in human tissues have been
Fig. 6 Analysis of mRNA 
expression under normoxic and 
hypoxic conditions in human 
colon carcinoma cells, a HIF-1, 
b MDR1; N normoxia; 
H hypoxia; A Absorbance123
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cytoplasmic staining patterns were observed in these stud-
ies. HIF-1 expression was absent in most normal tissues,
and the staining patterns were variable in each organ. In our
study, HIF-1 immunoreactivity was localized in the cyto-
plasm and/or nuclei of colon carcinoma cells. The reason
for these diVerences in staining patterns is unknown. We
observed two distinct patterns of HIF-1 immunostaining.
One pattern was heterogeneous and was detected only in
viable tumor cells surrounding the area of necrosis, whereas
the other pattern was diVuse and homogeneous. The hetero-
geneous staining may have been the result of hypoxia,
whereas the homogeneous pattern may have been due to
regulatory modes other than hypoxia. Expression of HIF-1
is enhanced by genetic alterations in tumor suppressor
genes (p53, PTEN) and oncogenes (v-src, H-ras) and by the
induction of several growth factors (insulin-like growth
factor (IGF)-1 and IGF-2, basic Wbroblast growth factor
(bFGF), and epidermal growth factor (EGF)). It is possible
that the homogeneous HIF-1 immunostaining pattern in
colon carcinoma was associated with these factors, at least
in part (Kimura et al. 2004). Additional studies are needed
to elucidate these associations.
For examining the expression changes of HIF-1 and
P-gp in hypoxia, we cultured human colon carcinoma cells
(HCT-116, HT-29, LoVo, and SW480) respectively under
normoxic and hypoxic conditions, and immunochemically
detected the expression of them. Our results showed that
HIF-1 mainly existed in cytoplasm and nuclei. P-gp, as a
transmembrane protein, mainly exists in the cytomembrane
and cytoplasm of the four types of cells. We found that the
expression of HIF-1 and P-gp were positively correlated.
The expression of HIF-1 and P-gp in the experimental
cells were both up-regulated after incubation under hypoxia
for 24 h, while under the normal PaO2 the expression of
HIF-1 was just quite weakly detected, and little P-gp
immunoreactivity was observed, respectively with the
diVerences being statistically signiWcant. Also, the consis-
tent data results with immunocytochemistry were further
given by using RT-PCR. The high expression of P-gp may
increase the stability of the tumor cells under hypoxic con-
ditions. The PaO2 of body organs (except marrow and carti-
lage) is generally normal, so the HIF-1 may serve as a new
target for the molecular treatment of tumor. Combining
with the results of tissue specimens and other reported data,
it suggests that hypoxia induce the overexpression of HIF-1
and MDR1/P-gp in colon carcinoma, and HIF-1 expres-
sion may be associated with the gene MDR1 (P-gp) and
interactively involved in the occurrence of tumor multidrug
resistance.
The data of the recent study demonstrate that intrinsic
expression of P-gp in multicellular tumor spheroids is regu-
lated by hypoxic conditions in the depth of the tissue and
requires the presence of HIF-1. However, it is currently
unknown how HIF-1 may regulate the expression of P-gp.
The sequenced MDR1 gene coding for P-gp was cloned
several years ago (Roninson et al. 1984, 1986) and does not
contain any HIF-1 binding sites, which suggests that P-gp
is not under the direct control of HIF-1 but may be indi-
rectly regulated, e.g., by transactivation. However, it cannot
be excluded that the hypoxia response elements of genes
binding to HIF-1 are located at some distance from the cod-
ing region of the gene. It was recently demonstrated that
induction of the murine MDR1 gene by the polycyclic aro-
matic hydrocarbon 3-methylcholanthrene requires a func-
tional heterodimer of the aromatic hydrocarbon receptor
and ARNT as well as activation of the tumor suppressor
and transcription factor p53. This Wnding indicates that
under the experimental conditions used in the present
study, i.e., under hypoxia, MDR1 expression may require a
functional HIF-1/ARNT heterodimer and presumably
activation of p53. In this respect, it has been convincingly
shown that mutant p53 up-regulates the MDR1 gene via
Ets-1 (Sampath et al. 2001), which is a transcription factor
under the control of HIF-1 and up-regulated under hypoxic
conditions (Oikawa et al. 2001). Furthermore, HIF-1 may
regulate MDR1 expression via protein kinase A-dependent
activation of cAMP-positive factors, which were previously
shown to exert a positive regulatory eVect on MDR1 tran-
scription. The cAMP response element binding factor
(CREB) promotes cellular gene expression, after its phos-
phorylation at Ser133, via recruitment of the coactivator
paralogs CREB binding protein (CBP) and p300. Thus, it
was hypothesized that p53 and HIF-1 functions are diVer-
ently regulated by CBP and may independently activate
transcription, e.g., transcription of the MDR1 gene. Alter-
natively, a convergence of CBP-dependent, HIF-1- and
p53-mediated pathways may be required for activation of
the MDR1 gene and establishment of the MDR phenotype.
In conclusion, we showed that HIF-1 expression is sig-
niWcantly associated with MDR1/P-gp expression in human
colon carcinoma. The dissection of the multistep regulation
of MDR1 gene under hypoxic conditions is just beginning.
Further studies will add to the understanding of how HIF-1
was involved in multidrug resistance with MDR1 gene in
malignant tumors and will help Wnd a novel strategy for the
reversal of MDR.
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